NOVOLOG 100 [iU]/mL

NOVOLOG 100 [iU]/mL is a rapid-acting insulin aspart injection used for managing blood glucose levels in diabetes. This solution is designed for subcutaneous or intravenous administration, offering flexible dosing options.

NOVOLOG 100 [iU]/mL is primarily used to control blood sugar levels in adults and children with diabetes. It is often administered before meals to help manage postprandial glucose spikes. This rapid-acting insulin aspart is commonly prescribed for individuals requiring precise blood sugar control, including those with type 1 or type 2 diabetes.

NOVOLOG 100 [iU]/mL works by mimicking the action of natural insulin in the body, helping to lower blood sugar levels after meals. Users may experience effects within 10 to 20 minutes of administration, with peak activity occurring around 1 to 3 hours post-injection. The duration of action typically lasts for 3 to 5 hours.

NOVOLOG 100 [iU]/mL should be handled with care to avoid contamination. It is essential to store it properly to maintain its efficacy. Users should be aware of the signs of hypoglycemia and have a plan in place to manage low blood sugar levels. Always follow the guidance of a healthcare provider when using this medication.

NOVOLOG 100 [iU]/mL may interact with other medications, including oral hypoglycemic agents, beta-blockers, and alcohol. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption can also affect blood sugar levels and should be monitored carefully.